A detailed history of Knoll Capital Management, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Knoll Capital Management, LLC holds 600,400 shares of OCUL stock, worth $5 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares
600,400
Previous 200,400 199.6%
Holding current value
$5 Million
Previous $1.37 Million 281.24%
% of portfolio
2.58%
Previous 0.93%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.45 - $9.23 $2.58 Million - $3.69 Million
400,000 Added 199.6%
600,400 $5.22 Million
Q4 2023

Feb 14, 2024

BUY
$2.08 - $4.52 $416,000 - $903,999
200,000 Added 50000.0%
200,400 $893,000
Q3 2023

Nov 14, 2023

SELL
$3.14 - $5.04 $626,744 - $1.01 Million
-199,600 Reduced 99.8%
400 $1,000
Q1 2023

May 15, 2023

BUY
$2.79 - $6.27 $558,000 - $1.25 Million
200,000 New
200,000 $1.05 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $641M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Knoll Capital Management, LLC Portfolio

Follow Knoll Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.